We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
L-Caldesmon antibody
Caldesmon, CDM
Gene name: CALD1, CAD, CDM
Gene name: CALD1, CAD, CDM
As low as
€278.30
In stock
Ref
00013407
Actin- and myosin-binding protein implicated in the regulation of actomyosin interactions in smooth muscle and nonmuscle cells (could act as a bridge between myosin and actin filaments). Stimulates actin binding of tropomyosin which increases the stabilization of actin filament structure. In muscle tissues, inhibits the actomyosin ATPase by binding to F-actin. This inhibition is attenuated by calcium-calmodulin and is potentiated by tropomyosin. Interacts with actin, myosin, two molecules of tropomyosin and with calmodulin. Also play an essential role during cellular mitosis and receptor capping. Involved in Schwann cell migration during peripheral nerve regeneration
ID Covalab | pab0187 |
---|---|
Product type | Primary antibodies |
Clonality | Polyclonal antibody |
Raised in | Rabbit |
Immunogen | A 15 residue synthetic peptide derived from human L-Caldesmon |
Activity cross reaction | Reacts with human L-Caldesmon. |
Species | Hu |
Labelling | None |
Form | Antiserum |
Preservative | None |
Storage instructions | Lyophilized powder stable for a minimum of 2 years at -20°C. Store reconstituted antibodies at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt. |
Target | L-Caldesmon |
Uniprot ID | Q05682 |
Gene ID | 800 |
Applications | ELISA, IHC, WB |
Working dilutions | Optimal dilution should be determined by the end user. The following are guidelines only : IHC (1:50 - 1:500) WB (1:200 - 1:5000) |
Publication | * Zheng PP, van der Weiden M, Kros JM. Differential expression of Hela-type caldesmon in tumour neovascularization: a new marker of angiogenic endothelial cells. J Pathol. 2005 Feb,205(3):408-14. (IHC-P) |
Write Your Own Review